A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.

Trial Profile

A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Remimazolam (Primary) ; Midazolam
  • Indications Sedation
  • Focus Registrational; Therapeutic Use
  • Sponsors PAION
  • Most Recent Events

    • 01 Aug 2017 Last checked against ClinicalTrials.gov record.
    • 19 Oct 2016 Results published in a PAION media release.
    • 23 Sep 2016 According to a PAION media release, results of this trial were presented at the American College of Gastroenterology 2016 Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top